CGAS and cancer: Accumulating evidence suggests key proteins in the cGAS-STING signaling pathway as potential drug targets, and relevant agonists could fundamentally improve the efficacy of current cancer treatments, including surgery, chemotherapy, radiotherapy, and immunotherapy (Su et al., 2019).